Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR achieves 60 per cent reduction in osteoarthritis pain

Aug 15, 2018 at 2:30 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment